Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here's Why [Yahoo! Finance]
GlaxoSmithKline PLC (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: Yahoo! Finance
The same day, GSK plc (NYSE:GSK) announced that the European Commission approved Shingrix, its Recombinant Zoster Vaccine or RZV, in a prefilled syringe. The vaccine presentation currently includes two vials, one with a lyophilised powder antigen and another with a liquid adjuvant, with the lyophilised powder antigen requiring reconstitution. The suspension in the adjuvant vial is withdrawn and injected into the antigen vial. However, the new prefilled syringe simplifies the vaccine administration process for healthcare professionals as it eliminates the requirement to follow these steps before administration. Tony Wood, Chief Scientific Officer, GSK plc (NYSE:GSK), stated that the new presentation of Shingrix is specially designed to ease administration, allowing healthcare professionals to deliver improved protection against shingles, a painful disease that can have serious and long-lasting complications. Management further reported that the approval is based on data confirmin
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GlaxoSmithKline PLC news events
Weekly update
A roundup of the hottest topics
GSK
News
- GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- GSK (NYSE:GSK) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.MarketBeat
- Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? [Yahoo! Finance]Yahoo! Finance
- HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target [Yahoo! Finance]Yahoo! Finance
- Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSKPR Newswire
GSK
Sec Filings
- 1/16/26 - Form 6-K
- 1/15/26 - Form 6-K
- 1/13/26 - Form 6-K
- GSK's page on the SEC website